二代结肠胶囊内镜检测溃疡性结肠炎黏膜病变与疾病活动度的前瞻性研究(附视频)
这项前瞻性研究在同一天对溃疡性结肠炎患者进行二代结肠胶囊内镜(CCE-2)与常规结肠镜检查,评估者相互盲法,以结肠镜为参考标准。结果显示两者在 Mayo 内镜评分和 UCEIS 上具有高度一致性,CCE-2 检测黏膜炎症敏感度高,患者耐受性更好。
要点
- CCE-2 与结肠镜在 Mayo 内镜评分和 UCEIS 上均呈高度一致性。
- CCE-2 检测黏膜炎症(MES>0)敏感度 97%,检测中重度炎症(MES>1)敏感度 94%。
- 患者对 CCE-2 的耐受性优于结肠镜,并更倾向于选择 CCE-2。
核心结论
- CCE-2 在检测溃疡性结肠炎黏膜病变和判断疾病严重程度方面具有高准确度,是耐受性好且可靠的疾病监测工具。
研究设计与样本
- 前瞻性研究,同一天对溃疡性结肠炎患者进行二代结肠胶囊内镜(CCE-2)和常规结肠镜检查,CCE-2 阅片者与结肠镜操作者对彼此结果盲法。
- 共入组 150 例患者,其中 108 例纳入按患者分析。
- 临床试验注册号:NCT02469103。
主要发现
- CCE-2 与结肠镜在 Mayo 内镜评分(MES)上的一致性为组内相关系数(ICC)0.69(95% CI 0.46-0.81,P < .001),在 UCEIS 上 ICC 为 0.64(95% CI 0.38-0.78,P < .001)。
- CCE-2 检测黏膜炎症(MES>0)的敏感度为 97%,检测中重度炎症(MES>1)的敏感度为 94%。
- 在按肠段分析中,CCE-2 检测黏膜炎症(包括血管纹理消失、出血和糜烂)的阴性预测值达 94% 至 95%。
- 两名独立 CCE-2 阅片者对两种评分系统的观察者间一致性良好(ICC > .80)。
- CCE-2 检测炎性息肉的敏感度和特异度分别为 100% 和 91%。
关键数值与推荐
- 黏膜炎症判定标准:MES>0 为存在黏膜炎症,MES>1 为中重度炎症。
- 黏膜炎症包括血管纹理消失、出血和糜烂。
- 观察者间一致性良好定义为 ICC > .80。
临床怎么用
- CCE-2 可作为溃疡性结肠炎疾病监测中耐受性好且可靠的检查工具。
- 原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Mucosal healing is the goal for ulcerative colitis (UC) therapy, but it needs to be confirmed via colonoscopy. Colon capsule endoscopy (CCE) is a noninvasive technique for colon investigation. Our study investigated the accuracy of second-generation CCE (CCE-2) in assessing mucosal lesions and disease activity in UC. METHODS: In this prospective study, CCE-2 and conventional colonoscopy were performed on the same day. CCE-2 reviewers and colonoscopists used the Mayo endoscopic subscore (MES) and the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) to assess disease activity, and they were blinded to each other's findings. Diagnostic parameters of CCE-2 for identifying mucosal lesions were evaluated by using colonoscopy as the reference. RESULTS: A total of 150 patients were enrolled. Of the 150 patients, 108 were included for per-patient analysis. CCE-2 and colonoscopy showed substantial agreement in measuring MES (intraclass correlation coefficient [ICC] 0.69; 95% confidence interval [CI], 0.46-0.81; P < .001) and UCEIS (ICC 0.64; 95% CI, 0.38-0.78; P < .001). CCE-2 had a sensitivity of 97% and 94% to detect mucosal inflammation (MES >0) and moderate to severe inflammation (MES >1), respectively. In per-segment analysis, the negative predictive values of CCE-2 to detect mucosal inflammation, including vascular pattern loss, bleeding, and erosions reached 94% to 95%. Interobserver agreement between 2 independent CCE-2 readers for both scoring systems was good (ICC > .80). The sensitivity and specificity of CCE-2 in detecting postinflammatory polyps were 100% and 91%, respectively. CCE-2 was better tolerated and preferred by patients than was colonoscopy. CONCLUSIONS: CCE-2 yields high accuracy in detecting mucosal lesions and determining disease severity in UC. It represents a well-tolerated and reliable tool for disease monitoring in UC. (Clinical trial registration number: NCT02469103.).
引用
- Shi HY, Chan FKL, Higashimori A, et al. A prospective study on second-generation colon capsule endoscopy to detect mucosal lesions and disease activity in ulcerative colitis (with video). Gastrointest Endosc. 2017. PMID: 28713062. doi:10.1016/j.gie.2017.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。